Careers  |  Sign In  |  Register  |   Twitter

β-blockers Found to Not Reduce Heart Problems

β-Blockers have long been prescribed as medication following a myocardial infarction (MI). However, new research published in The Journal of the American Medical Association investigated the use of β-Blockers in patients with coronary artery disease (CAD) but no history of MI, those with a remote history of MI, and those with only risk factors for CAD. Researchers found that in “patients with either CAD risk factors only, known prior MI, or known CAD without MI, the use of β-blockers was not associated with a lower risk of composite cardiovascular events.”

Read it in JAMA.